Display Settings:

Format

Send to:

Choose Destination
    Clin Invest Med. 2010 Dec 1;33(6):E342-8.

    Discovery research to clinical trial: a ten year journey.

    Source

    Anatomical Pathology, Vancouver Hospital & Health Sciences Ctr., 855 West 12th Avenue, Vancouver, British Columbia. torsten@interchange.ubc.ca

    Abstract

    Clinician-scientists have the training and motivation to translate basic science into tools for improved clinical care, but the road to achieve this is hardly straight forward, particularly for large scale genomic datasets. This year's Joe Doupe Young Investigator award winner, Dr. Torsten Nielsen, details successful examples of new scientific insights, diagnostics and clinical trials that have resulted from microarray-based gene expression profiling of sarcomas: TLE1 as a biomarker for synovial sarcoma, histone deacetylase inhibitor therapy for translocation-associated sarcomas of young adults, and CSF1 pathway inhibitors for tenosynovial giant cell tumors. Results from exciting, emerging next generation sequencing technologies will need to undergo similar validation and preclinical studies before they can be expected to impact patient care.

    PMID:
    21134335
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk